Arcus Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Arcus Biosciences
RCUS Stock  USD 25.70  0.25  0.98%   
Arcus Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Arcus Biosciences' valuation are provided below:
Gross Profit
-263 M
Profit Margin
(1.42)
Market Capitalization
3.1 B
Enterprise Value Revenue
10.1204
Revenue
240 M
There are over one hundred nineteen available fundamental signals for Arcus Biosciences, which can be analyzed over time and compared to other ratios. All traders should validate Arcus Biosciences' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 2.7 B in 2025. Enterprise Value is likely to gain to about 2.6 B in 2025

Arcus Biosciences Total Revenue

270.9 Million

Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 50.4 M, Interest Income of 54.6 M or Depreciation And Amortization of 5.2 M, as well as many indicators such as Price To Sales Ratio of 4.94, Dividend Yield of 0.0 or PTB Ratio of 3.11. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Arcus Stock
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Arcus Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets822.9 M1.1 B513.3 M
Slightly volatile
Other Current Liabilities115.5 M110 M29.6 M
Slightly volatile
Total Current Liabilities115.9 M226 M68.6 M
Slightly volatile
Total Stockholder Equity440 M485 M289.8 M
Slightly volatile
Other Liabilities456.4 M434.7 M146.5 M
Slightly volatile
Property Plant And Equipment Net53.1 M47 M33.7 M
Slightly volatile
Accounts Payable11.8 M18 M8.2 M
Slightly volatile
Cash134.1 M150 M101.4 M
Slightly volatile
Non Current Assets Total133.7 M134 M80.5 M
Slightly volatile
Non Currrent Assets Other76.7 M73 M17.9 M
Slightly volatile
Other Assets8.5 M16.1 M5.9 M
Slightly volatile
Cash And Short Term Investments573.6 M978 M366.3 M
Slightly volatile
Net Receivables23.8 M25 M55.3 M
Pretty Stable
Common Stock Shares Outstanding60.2 M90.1 M43.7 M
Slightly volatile
Short Term Investments439.6 M828 M264.9 M
Slightly volatile
Liabilities And Stockholders Equity822.9 M1.1 B513.3 M
Slightly volatile
Non Current Liabilities Total266.9 M439 M154.9 M
Slightly volatile
Capital Surpluse1.4 B1.3 B471.9 M
Slightly volatile
Other Current Assets10.5 M13 M6.2 M
Slightly volatile
Total Liabilities382.9 M665 M223.6 M
Slightly volatile
Property Plant And Equipment Gross53.1 M88 M33.7 M
Slightly volatile
Preferred Stock Total Equity190.1 M260.1 M179.4 M
Slightly volatile
Total Current Assets689.2 M1 B432.9 M
Slightly volatile
Non Current Liabilities Other143.6 M157 M82.5 M
Slightly volatile
Common Stock1.7 B1.6 B364.5 M
Slightly volatile
Property Plant Equipment163 M155.2 M45.2 M
Slightly volatile
Current Deferred Revenue64.3 M85 M35.4 M
Slightly volatile
Common Stock Total Equity5.3 K8.1 K4.5 K
Slightly volatile
Deferred Long Term Liabilities2.6 M2.7 M4.1 M
Pretty Stable
Net Invested Capital487.9 M533 M319.6 M
Slightly volatile
Net Working Capital632.1 M790 M398.6 M
Slightly volatile
Short Term Debt7.2 M12 M5.1 M
Slightly volatile
Capital Stock1.7 B1.6 B364.5 M
Slightly volatile
Short and Long Term Debt Total53 M60 M35.3 M
Slightly volatile
Capital Lease Obligations11.4 M12 M20.1 M
Pretty Stable
Long Term Debt38.4 M43.2 M47.1 M
Slightly volatile

Arcus Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income50.4 M48 M10.3 M
Slightly volatile
Interest Income54.6 M52 M11.1 M
Slightly volatile
Depreciation And Amortization5.2 M10 M3.5 M
Slightly volatile
Selling General Administrative61.9 M120 M37 M
Slightly volatile
Other Operating Expenses617.4 M588 M183.4 M
Slightly volatile
Research Development470.4 M448 M139.8 M
Slightly volatile
Cost Of Revenue9.5 M10 M42.5 M
Slightly volatile
Total Operating Expenses617.4 M588 M183.4 M
Slightly volatile
Total Other Income Expense Net49.4 M47 M10.2 M
Slightly volatile
Reconciled Depreciation5.8 M10 M4.1 M
Slightly volatile
Non Operating Income Net Other339.4 K357.3 K3.4 M
Slightly volatile
Selling And Marketing Expenses13.6 M15.3 M16.7 M
Slightly volatile

Arcus Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation79.8 M76 M24 M
Slightly volatile
Begin Period Cash Flow122.3 M130 M87.7 M
Slightly volatile
Other Cashflows From Financing Activities1.9 M2 M41.6 M
Slightly volatile
Depreciation6.3 M10 M4.1 M
Slightly volatile
Capital Expenditures9.8 M6 M7.2 M
Slightly volatile
Change To Operating Activities27.8 M26.4 M8.7 M
Slightly volatile
Total Cash From Financing Activities162.2 M277 M119.3 M
Slightly volatile
End Period Cash Flow135.2 M153 M102 M
Slightly volatile
Change To Netincome91.8 M87.4 M26.4 M
Slightly volatile
Issuance Of Capital Stock122 M228 M136.9 M
Very volatile
Dividends Paid4 M4.5 M4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.945.2156
Slightly volatile
PTB Ratio3.112.76623.3593
Slightly volatile
Days Sales Outstanding33.635.368269.7852
Slightly volatile
Book Value Per Share5.595.38295.7993
Slightly volatile
Stock Based Compensation To Revenue0.340.29460.3831
Pretty Stable
Capex To Depreciation0.510.542.2045
Slightly volatile
PB Ratio3.112.76623.3593
Slightly volatile
EV To Sales4.614.8511120
Slightly volatile
Payables Turnover0.360.50.4455
Slightly volatile
Sales General And Administrative To Revenue0.510.533.107
Slightly volatile
Research And Ddevelopement To Revenue1.651.736418.1302
Slightly volatile
Capex To Revenue0.02210.02332.0163
Slightly volatile
Cash Per Share6.9810.85466.8538
Slightly volatile
Days Payables Outstanding8599671.1 K
Slightly volatile
Current Ratio4.274.495612.0286
Slightly volatile
Tangible Book Value Per Share5.595.38295.7993
Slightly volatile
Receivables Turnover9.810.3246.1497
Slightly volatile
Shareholders Equity Per Share5.595.38295.7993
Slightly volatile
Debt To Equity0.07990.12370.0552
Slightly volatile
Capex Per Share0.06330.06660.1624
Very volatile
Revenue Per Share3.012.86351.0625
Slightly volatile
Interest Debt Per Share1.00.71030.5204
Slightly volatile
Debt To Assets0.03910.05220.0301
Slightly volatile
Graham Number11.5613.014.1746
Slightly volatile
Operating Cycle33.635.368269.7852
Slightly volatile
Price Book Value Ratio3.112.76623.3593
Slightly volatile
Days Of Payables Outstanding8599671.1 K
Slightly volatile
Ebt Per Ebit1.050.85760.9702
Slightly volatile
Company Equity Multiplier1.332.37111.4323
Slightly volatile
Long Term Debt To Capitalization0.07210.08110.0884
Slightly volatile
Total Debt To Capitalization0.07020.11010.0502
Slightly volatile
Debt Equity Ratio0.07990.12370.0552
Slightly volatile
Quick Ratio4.274.495612.3712
Slightly volatile
Net Income Per E B T0.80.920.9567
Slightly volatile
Cash Ratio0.630.66376.3808
Slightly volatile
Days Of Sales Outstanding33.635.368269.7852
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.21.03531.1819
Slightly volatile
Price To Book Ratio3.112.76623.3593
Slightly volatile
Fixed Asset Turnover5.765.48941.6377
Slightly volatile
Debt Ratio0.03910.05220.0301
Slightly volatile
Price Sales Ratio4.945.2156
Slightly volatile
Asset Turnover0.240.22430.0725
Slightly volatile
Price Fair Value3.112.76623.3593
Slightly volatile

Arcus Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.7 B2.5 B1.2 B
Slightly volatile
Enterprise Value2.6 B2.5 B1.1 B
Slightly volatile

Arcus Fundamental Market Drivers

Arcus Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue85 M64.3 M
Total Revenue258 M270.9 M
Cost Of Revenue10 M9.5 M
Stock Based Compensation To Revenue 0.29  0.34 
Sales General And Administrative To Revenue 0.53  0.51 
Research And Ddevelopement To Revenue 1.74  1.65 
Capex To Revenue 0.02  0.02 
Revenue Per Share 2.86  3.01 
Ebit Per Revenue(1.28)(1.34)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY